The presence of tau protein was originally included in the description of neuronal injury, but since 2018, AD has been stratified by "ATN" (A for amyloid, T for tau, and N for neuronal injury) in the continuing efforts to understand the disease progression of AD, and tau deposition is now described as independent from neuronal injury (2, 3). The gene discussed is MAPT; the disease is Alzheimer disease.